Effect of distribution of solid and liquid lipid domains on transport of free radicals in nanostructured lipid carriers

LWT

Volumn 64, Issue 1, 2015, Pages 14-17

  Davis, Sharifa ^b   Haldipur, Janhavi ^b   Zhao, Yuan ^b   Dan, Nily ^a   Pan, Yuanjie ^c   Nitin, Nitin ^c   Tikekar, Rohan V ^d  

^a Drexel University   (United States)

^b DREXEL UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Encapsulation; Nanostructured lipid carriers; Peroxyl radicals

Indexed keywords

BLENDING; ENCAPSULATION; FLUORESCENCE IMAGING; FREE RADICALS;

AQUEOUS PHASE; FLUORESCENT DYES; LIPID EMULSIONS; NANOSTRUCTURED LIPID CARRIERS; OXIDATIVE STABILITY; PEROXYL RADICAL; TRANSPORT RATE; UNIFORM DISTRIBUTION;

LIQUIDS;

EID: 84953875236     PISSN: 00236438     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lwt.2015.05.013     Document Type: Article

References (19)

1. Bricarello D.A., Prada M.J., Nitin N. Physical and chemical modifications of lipid structures to inhibit permeation of free radicals in a supported lipid membrane model. Soft Matter 2012, 8(43):11144-11151. 10.1039/C2sm26474a.
2. Chinsriwongkul A., Chareanputtakhun P., Ngawhirunpat T., Rojanarata T., Sila-on W., Ruktanonchai U., et al. Nanostructured Lipid Carriers (NLC) for parenteral delivery of an anticancer drug. AAPS PharmSciTech 2012, 13(1):150-158. 10.1208/s12249-011-9733-8.
3. Crank J. Mathematics of diffusion 1975, Oxford Science Publications.
4. Dan N. Nanostructured lipid carriers: effect of solid phase fraction and distribution on the release of encapsulated materials. Langmuir 2014, 30(46):13809-13814. 10.1021/La5030197.
5. Fang J.Y., Fang C.L., Liu C.H., Su Y.H. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). European Journal of Pharmaceutics and Biopharmaceutics 2008, 70(2):633-640. 10.1016/j.ejpb.2008.05.008.
6. Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Surfaces. B Biointerfaces 2005, 45(3-4):167-173. 10.1016/j.colsurfb.2005.08.005.
7. Khalil R.M., Abd-Elbary A., Kassem M.A., Ghorab M.M., Basha M. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam. Pharmaceutical Development and Technology 2014, 19(3):304-314. 10.3109/10837450.2013.778872.
8. zur Muhlen A., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. European Journal of Pharmaceutics and Biopharmaceutics 1998, 45(2):149-155. 10.1016/s0939-6411(97)00150-1.
9. Muller R.H., Petersen R.D., Hornmoss A., Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Advanced Drug Delivery Reviews 2007, 59(6):522-530. 10.1016/j.addr.2007.04.012.
10. Muller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Reviews 2002, 54:S131-S155. pii:S0169-409x(02)00118-7. 10.1016/S0169-409x(02)00118-7.
11. Pardeike J., Hommoss A., Mueller R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. International Journal of Pharmaceutics 2009, 366(1-2):170-184. 10.1016/j.ijpharm.2008.10.003.
12. Shen J., Sun M.J., Ping Q.N., Ying Z., Liu W. Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Nanotechnology 2010, 21(2). doi: Artn 025101. 10.1088/0957-4484/21/2/025101.
13. Tamjidi F., Shahedi M., Varshosaz J., Nasirpour A. Nanostructured lipid carriers (NLC): a potential delivery system for bioactive food molecules. Innovative Food Science & Emerging Technologies 2013, 19:29-43. 10.1016/j.ifset.2013.03.002.
14. Teeranachaideekul V., Souto E.B., Junyaprasert V.B., Muller R.H. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies. European Journal of Pharmaceutics and Biopharmaceutics 2007, 67(1):141-148. 10.1016/j.ejpb.2007.01.015.
15. Tikekar R.V., Nitin N. Effect of physical state (solid vs. liquid) of lipid core on the rate of transport of oxygen and free radicals in solid lipid nanoparticles and emulsion. Soft Matter 2011, 7(18):8149-8157. 10.1039/C1sm05031a.
16. Tikekar R.V., Nitin N. Distribution of encapsulated materials in colloidal particles and its impact on oxidative stability of encapsulated materials. Langmuir 2012, 28(25):9233-9243. 10.1021/la301435k.
17. Wang J.J., Liu K.S., Sung K.C., Tsai C.Y., Fang J.Y. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. European Journal of Pharmaceutical Sciences 2009, 38(2):138-146. 10.1016/j.ejps.2009.06.008.
18. Wissing S.A., Kayser O., Müller R.H. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews 2004, 56(9):1257-1272. 10.1016/j.addr.2003.12.002.
19. Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., Yang C.Z. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. Journal of Controlled Release 1999, 59(3):299-307. 10.1016/s0168-3659(99)00007-3.